3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
53
Ovarian Neoplasms
4
Prostatic Neoplasms
3
Neoplasms
3
Inflammatory Breast Neoplasms
3
HER2-positive Breast Cancer
3
Carcinoma, Non-Small-Cell Lung
3
Stomach Neoplasms
2
Solid Tumor
2
Rectal Neoplasms
2
Neoplasm Metastasis
2
Colonic Neoplasms
2
Urinary Bladder Neoplasms
1
Solid Cancers
1
Patient Preference
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors
1
Neuroblastoma
1
Neoplasms, Unknown Primary
1
Multiple Endocrine Neoplasia
1
Malignant Solid Neoplasm
1
Lung Neoplasms
1
Locally Advanced Breast Cancer
1
Her2-Positive Breast Cancer
1
HER2-positive Metastatic Breast Cancer
1
HER2-positive Early Breast Cancer
1
HER2-Positive Early Breast Cancer
1
HER2 Positive Breast Cancer
1
Fallopian Tube Neoplasms
1
Colorectal Neoplasms
1
Interventions
fludarabine phosphate
87
Cyclophosphamide
78
Whole-Body Irradiation
59
Azacitidine
59
fludarabine
56
Mycophenolic Acid
56
Busulfan
53
Tacrolimus
51
Peripheral Blood Stem Cell Transplantation
41
Melphalan
40
Cytarabine
38
Antilymphocyte Serum
38
Filgrastim
37
Granulocyte Colony-Stimulating Factor
33
Cyclosporine
33
Methotrexate
32
Decitabine
32
thymoglobulin
22
Thiotepa
21
Clofarabine
21
Cord Blood Stem Cell Transplantation
19
Stem Cell Transplantation
16
Alemtuzumab
16
Sirolimus
15
Rituximab
15
sargramostim
12
Lenalidomide
12
Etoposide
11
Radiotherapy
10
Cyclosporins
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Myelodysplastic Syndromes
×
pertuzumab
×
Clear all
No trials found.